Congressman Leonard Lance

Representing the 7th District of New Jersey

Healthcare

 

More on Healthcare

Apr 19, 2018 Press Release

WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07), member of the Energy and Commerce Health Subcommittee, today announced the Department of Health and Human Services has awarded the State of New Jersey nearly $13 million in new funding to combat the opioid crisis.

Feb 9, 2018 Press Release

WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07) released the following statement after passage of the Bipartisan Budget Act, which included Lance priorities such as Medicaid funding for Puerto Rico:   

Sep 22, 2017 Press Release

FLEMINGTON, N.J. --- Congressman Leonard Lance (NJ-07) today announced Community in Crisis, Inc., Hunterdon Prevention Resource, Inc. and Empower Somerset, Inc. have each been awarded a $125,000 grant by the Drug-Free Communities Support Program and the White House Office of National Drug Control Policy.  The grants are designed to assist communities addressing the problem of opioid and heroin abuse, provide education and implement prevention measures.

Sep 13, 2017 Press Release

WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07), member of the Energy and Commerce Health Subcommittee, released the following statement after the release of a single-payer health care plan in the U.S. Senate.

“Senator Sanders’ single-payer health care plan is one that my constituents cannot afford.  Most Americans would lose their health insurance plans if single-payer became law and dramatic tax increases would be unavoidable.  Those tax increases would fall across the board to meet the tremendous cost of the program.

May 2, 2017 Press Release

WASHINGTON, D.C. --- U.S. Representatives Leonard Lance (NJ-07) and Diana DeGette (CO-01) have introduced bipartisan legislation called the Patient Experience in Research Act of 2017 (PERA) in the U.S. House of Representatives.  PERA will launch a pilot project to evaluate the psychological and social distress experienced by patients participating in a clinical trial of a drug or biological product that is intended to treat a serious or life-threatening disease or condition. 

Pages